Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Payables (2019 - 2025)

Historic Payables for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $10.2 million.

  • CureVac's Payables fell 3085.03% to $10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year decrease of 3085.03%. This contributed to the annual value of $18.5 million for FY2024, which is 6428.68% down from last year.
  • According to the latest figures from Q3 2025, CureVac's Payables is $10.2 million, which was down 3085.03% from $8.6 million recorded in Q2 2025.
  • In the past 5 years, CureVac's Payables ranged from a high of $146.1 million in Q4 2021 and a low of $8.1 million during Q2 2024
  • Over the past 5 years, CureVac's median Payables value was $19.3 million (recorded in 2024), while the average stood at $41.5 million.
  • In the last 5 years, CureVac's Payables surged by 12107174.03% in 2021 and then crashed by 7741.68% in 2023.
  • Quarter analysis of 5 years shows CureVac's Payables stood at $146.1 million in 2021, then tumbled by 48.7% to $75.0 million in 2022, then crashed by 31.05% to $51.7 million in 2023, then crashed by 64.29% to $18.5 million in 2024, then tumbled by 44.8% to $10.2 million in 2025.
  • Its last three reported values are $10.2 million in Q3 2025, $8.6 million for Q2 2025, and $9.9 million during Q1 2025.